APA (7th ed.) Citation

Stratmann, J. A., Michels, S., Hornetz, S. E. T., Christoph, D. C., Sackmann, S., Spengle, W., . . . Sebastian, M. (2018). Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M‑positive non‑small cell lung cancer. Journal of cancer research and clinical oncology, 144(12), . https://doi.org/10.1007/s00432-018-2754-x

Chicago Style (17th ed.) Citation

Stratmann, Jan A., et al. "Efficacy and Safety Analysis of the German Expanded Access Program of Osimertinib in Patients with Advanced, T790M‑positive Non‑small Cell Lung Cancer." Journal of Cancer Research and Clinical Oncology 144, no. 12 (2018). https://doi.org/10.1007/s00432-018-2754-x.

MLA (9th ed.) Citation

Stratmann, Jan A., et al. "Efficacy and Safety Analysis of the German Expanded Access Program of Osimertinib in Patients with Advanced, T790M‑positive Non‑small Cell Lung Cancer." Journal of Cancer Research and Clinical Oncology, vol. 144, no. 12, 2018, https://doi.org/10.1007/s00432-018-2754-x.